|

Post-Market Clinical Follow-up of Intra-Articular Hyaluronic Acid in Hip Osteoarthritis

RECRUITINGSponsored by Meiji Pharma Spain S.A.
Actively Recruiting
SponsorMeiji Pharma Spain S.A.
Started2026-01-29
Est. completion2027-04
Eligibility
Age40 Years+
Healthy vol.Accepted

Summary

The study population consists of approximately 40 adult outpatients aged 40 years or older with symptomatic hip osteoarthritis of at least 1 year of clinical evolution, treated with intra-articular hyaluronic acid in routine clinical practice within the Traumatology and Rehabilitation departments of participating hospitals in Spain.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* Age: \>40 years at the time of study inclusion
* Preserved gait capability, with or without assistive devices
* Symptomatic hip arthropathy with a disease evolution of at least 1 year.
* Radiographic Kellgren-Lawrence grade II-III documented within the 12 months prior to study entry
* Total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score \>15
* Patient currently receiving intra-articular hyaluronic acid treatment within 3 months prior to study inclusion

Exclusion Criteria:

* Refusal to provide written informed consent
* Females who are pregnant, breastfeeding, or not using effective contraception
* Body Mass Index (BMI) ≥ 30 kg/m²
* Presence of other chronic or autoimmune diseases that could interfere with clinical evaluation
* History of hypersensitivity or allergy to hyaluronic acid or its derivatives
* Prior administration of intra-articular platelet-rich plasma (PRP) or intra-articular corticosteroids within 3 months, or intra-articular hyaluronic acid within 6 months prior to study entry

Conditions2

ArthritisHip OA

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.